FDA lists October 14 speaker-request deadline for children’s myopia advisory meeting
FDA’s meeting notice asks people seeking a formal oral presentation at its October 30 myopia-treatment advisory meeting to submit their request by October 14.
What the record says
Speaker requests are due on or before October 14, 2026.
Committee meeting scheduled October 30, 2026.
The electronic public-comment docket closes October 29 at 11:59 p.m. Eastern Time.
The Dermatologic and Ophthalmic Drugs Advisory Committee will discuss Sydnexis’s application for atropine sulfate ophthalmic solution 0.01%, proposed to slow myopia progression in children ages three and older. The meeting is scheduled October 30, from 8:30 a.m. to 3 p.m. Eastern Time, with in-person and online participation. Written comments received by October 19 will be supplied to the committee; comments through October 29 will be considered by FDA.
Source details and supporting locations.
Practical next step
Consult FDA’s notice and contact for the October 14 speaker-request process, participation details and docket FDA-2026-N-10606. Electronic comments are accepted until 11:59 p.m. Eastern Time October 29.
Limits and what is not established
The application and proposed indication are under discussion; this meeting announcement is not a drug approval or treatment recommendation. Advisory committee recommendations are non-binding. Speaker requests do not guarantee a speaking slot.
Sources checked October 14, 2026. Later notices may change instructions or arrangements.
Original sources
U.S. Food and Drug Administration: original information